CCL3L1 is a key proinflammatory mediator involved in activation of leukocytes, lymphocytes, and macrophages that has been specifically implicated in glioblastoma and breast cancer tumorigenesis (57, 58) and found to be upregulated in renal cell carcinoma derived monocytes (59). Here, CCL3L3 is linked to breast cancer.